文献速递老年综合评估老年慢病共病管理

适配基层医疗的老年综合评估成本效果研究

Cost-Effectiveness of Comprehensive Geriatric Assessment Adapted to Primary Care.
PubMed 文献 · J Am Med Dir Assoc · 2022-05-13

干预组总成本较对照组减少11275美元(95%CI -407至-22142),QALY差异为-0.05(95%CI -0.17至0.08),结论提示该干预在24个月随访时具有成本效果。

要点

  • 基层老年综合评估干预在24个月时总成本更低,QALY差异无统计学意义。
  • 成本效果平面中77.9%的观测位于东南象限,提示干预可能节约成本且效果更优。
  • 采用预测模型筛选高住院风险老人并实施低成本干预具有前景,但需进一步研究。

核心结论

  • 基层老年综合评估干预对高住院风险老年人可能在24个月随访时具有成本效果。

研究设计与样本

  • 原始试验纳入1304名≥75岁高住院风险个体,成本效果分析纳入369人(干预组185人,对照组184人),平均年龄83.9岁,57%为男性。

主要发现

  • 干预组与对照组总成本差异(增量成本)为-11275美元(95%CI -407至-22142)。
  • 增量效果为-0.05质量调整生命年(95%CI -0.17至0.08)。
  • 成本效果平面中77.9%的观测位于东南象限,提示干预组成本更低且效果更好。

关键数值与推荐

  • 主要结局为24个月随访时干预相关的增量成本效果比。
  • 健康相关生活质量采用EQ-5D-3L测量并计算质量调整生命年,所有结局按意向治疗分析并调整年龄、性别和风险评分。

临床怎么用

  • 在基层医疗中可考虑对高住院风险老年人实施老年综合评估干预,并关注其成本效果。
  • 采用预测模型筛选干预对象及低成本干预策略可能具有推广潜力,但需进一步验证。

局限性

  • 成本效果分析仅纳入原始试验1304人中的369人,样本量有限。
  • 研究结论需进一步研究证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To estimate the cost-effectiveness of a pragmatic trial of comprehensive geriatric assessment adapted to primary care, compared with care as usual. DESIGN: Within-trial cost-effectiveness study of a prospective controlled multicenter trial. SETTING AND PARTICIPANTS: Nineteen primary care practices in Sweden. The original trial included 1304 individuals aged ≥75 years at high risk of hospitalization selected using a prediction model. From the original trial, 369 individuals participated in the cost-effectiveness analysis, 185 in the intervention group and 184 in the control group. Mean age was 83.9 years and 57% of the participants were men. METHODS: We obtained health care costs from administrative registries. Community costs and health-related quality of life data were obtained from a questionnaire sent to participants. Health-related quality of life was measured using EQ-5D-3L and quality-adjusted life years were calculated. We analyzed all outcomes according to intention to treat, and adjusted them to age, gender, and risk score (risk of hospitalization in the next 12 months). The primary outcome was the incremental cost-effectiveness ratio associated with the intervention at follow-up after 24 months. RESULTS: The difference in total cost (incremental cost) between intervention and control groups was USD -11,275 (95% CI -407 to -22,142). The incremental effect in quality-adjusted life years was -0.05 (95% CI -0.17 to 0.08). In the cost-effectiveness plane that illustrates the uncertainty of the analysis, 77.9 of the observations were within the south-east quadrant, implying lower cost and greater effect in the intervention group. CONCLUSIONS AND IMPLICATIONS: The results suggests that a primary care comprehensive geriatric assessment intervention delivered to older adults at high risk of hospitalization is cost-effective at follow-up after 24 months. The use of a prediction model to select participants and an intervention with a low cost is promising but requires further study.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Nord M, Lyth J, Marcusson J, et al. Cost-Effectiveness of Comprehensive Geriatric Assessment Adapted to Primary Care. J Am Med Dir Assoc. 2022. PMID: 35577011. doi:10.1016/j.jamda.2022.04.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。